Restructuring hitting multinational drug firms

Foreign invested pharmaceutical firms have been taking steps to reduce their workforces as they brace for lower earnings due to the government’s pressure to reduce drug prices.

Three multinational firms, such as Sanofi Aventis Korea, AstraZeneca Korea and GlaxoSmithKline, saw their earnings decline in 2011, data showed Thursday.

According to the data compiled by Yakup.com, a corporate inf...